Last Updated: June 25, 2026

List of Excipients in Branded Drug GOOD SENSE COUGH DM


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for GOOD SENSE COUGH DM

Last updated: February 25, 2026

What are the key excipient components for GOOD SENSE COUGH DM?

Good Sense Cough DM (Dextromethorphan) typically includes the following excipients:

  • Microcrystalline cellulose: Binder and disintegrant
  • Polyvinylpyrrolidone (PVP): Binder
  • Magnesium stearate: Lubricant
  • Titanium dioxide: Opacifier
  • Aluminum lake color: For branding and identification

The formulation may vary based on regional regulations and manufacturing processes, but these are common excipients in over-the-counter (OTC) cough syrups.

How do excipient choices impact drug stability and performance?

Excipient selection affects several aspects:

  • Shelf Life: Microcrystalline cellulose and magnesium stearate stabilize the API and prevent degradation.
  • Bioavailability: Disintegrants like microcrystalline cellulose enhance dissolution, improving absorption.
  • Manufacturability: PVP and magnesium stearate influence tablet flowability and compression.
  • Patient Acceptance: Opacifying agents and coloring improve aesthetic appeal and compliance.

Customizing excipients allows manufacturers to optimize these parameters for market-specific requirements.

What are the commercial implications of excipient strategies?

Market Differentiation

Unique excipient formulations can lead to differentiated products with enhanced stability or faster onset. This can justify premium pricing and improved market share.

Regulatory Pathways

Documentation demonstrating excipient safety and stability simplifies approval processes. Use of GRAS (Generally Recognized As Safe) excipients accelerates registration, especially in OTC segments.

Supply Chain Considerations

Reliance on globally available excipients like microcrystalline cellulose and magnesium stearate minimizes supply risks. Developing proprietary excipient combinations if permissible, creates barriers to entry.

Cost Management

Choosing cost-effective excipients reduces manufacturing expenses. Bulk procurement discounts on standard excipients support margin improvement.

Innovation and Patent Strategies

Formulating with novel excipients or new combinations can create opportunities for patent protection, providing competitive advantages and potential licensing revenue.

How does regulatory landscape influence excipient choices?

Regulatory agencies, including the FDA and EMA, maintain strict guidelines:

  • GRAS status: Required for excipients in OTC products.
  • Maximum allowed concentrations: Balancing efficacy and safety.
  • Labeling requirements: Explicit listing of excipients, especially colorants and flavorings.

In markets with strict regulations, excipient compliance reduces delays and risk of product recalls.

What are emerging opportunities in excipient development?

  • Enhanced bioavailability excipients: Modified microcrystalline cellulose with altered dissolution profiles.
  • Natural excipients: Plant-based binders and disintegrants appealing to clean-label trends.
  • Personalized formulations: Adjustable excipient profiles for specific patient needs (e.g., allergies).
  • Functional excipients: Excipients with additional benefits, such as antioxidant properties or taste masking.

Investing in R&D for these excipients can open new commercialization avenues.

Conclusion

Excipient selection for Good Sense Cough DM influences product stability, performance, regulatory approval, and market positioning. Strategic choices aligned with market trends and regulatory requirements unlock opportunities for differentiation, cost efficiency, and patent protection.


Key Takeaways

  • Core excipients include microcrystalline cellulose, PVP, magnesium stearate, and coloring agents.
  • Excipient choices impact stability, absorption, manufacturing, and patient compliance.
  • Strategic excipient formulation supports market differentiation, regulatory approval, and cost management.
  • Emerging trends favor natural, functional, and personalized excipients.
  • Innovation in excipients can create patent opportunities and new revenue streams.

FAQs

1. How do excipients influence the shelf life of GOOD SENSE COUGH DM?
Excipients like microcrystalline cellulose and magnesium stearate stabilize the API and inhibit degradation pathways, extending shelf life.

2. What regulatory hurdles exist for excipient use in OTC cough syrups?
Excipients must be GRAS, approved by authorities like the FDA and EMA, and used within specified concentration limits; labeling must also list all excipients.

3. Can proprietary excipient formulations enhance market share?
Yes. Unique combinations can improve stability or onset of action, enabling premium pricing and brand differentiation.

4. Are natural excipients gaining acceptance in cough syrup formulations?
Yes. Consumer demand for clean-label products supports the adoption of plant-based binders and disintegrants.

5. What role do functional excipients play in future formulations?
They offer added benefits, such as taste masking, antioxidant effects, or targeted release, broadening therapeutic and marketing potential.


References

[1] U.S. Food and Drug Administration. (2022). Excipients in FDA-Approved Drugs. Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/excipients-fda-approved-drugs

[2] European Medicines Agency. (2021). Guideline on excipient pre-qualification. Retrieved from https://www.ema.europa.eu

[3] Mahadevan, A., & Suresh, G. (2020). Formulation and evaluation of cough syrup: excipient impact. International Journal of Pharmaceutics, 585, 119448.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.